.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

MORPHINE SULFATE Drug Profile

« Back to Dashboard
Morphine Sulfate is a drug marketed by Novel Labs Inc, Upsher Smith, Dava Pharms Inc, Roxane, Hospira, Vintage Pharms Llc, Impax Labs Inc, Nostrum Labs Inc, Par Pharm Inc, Mallinckrodt, Hospira Inc, Lannett Holdings Inc, Teva Pharms Usa, Tris Pharma Inc, Rhodes Pharms, Nesher Pharms, Fresenius Kabi Usa, Mylan Pharms Inc, Sun Pharm Inds Ltd, Actavis Elizabeth, Vistapharm, Mallinckrodt Inc, Watson Labs, Corepharma, Eurohlth Intl Sarl, Pharm Assoc, Paddock Llc, Mayne Pharma Inc, and Meridian Medcl Techn. and is included in fifty-one NDAs. It is available from forty-three suppliers. There are three patents protecting this drug.

This drug has fourteen patent family members in seven countries.

The generic ingredient in MORPHINE SULFATE is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for Tradename: MORPHINE SULFATE

Patents:3
Applicants:29
NDAs:51
Suppliers / Packagers: see list43
Drug Prices: :see details

Pharmacology for Tradename: MORPHINE SULFATE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
MORPHINE SULFATE
morphine sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS204223-004Oct 30, 2013RXYes9,192,608► subscribe ► subscribe
Vistapharm
MORPHINE SULFATE
morphine sulfate
SOLUTION;ORAL201947-001Jan 5, 2012RXNo► subscribe► subscribe
Hospira Inc
MORPHINE SULFATE
morphine sulfate
INJECTABLE;INJECTION202515-005Nov 14, 2011RXYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MORPHINE SULFATE

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2014140097► subscribe
China104528165► subscribe
Japan2016512210► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc